Drug Shortage Report for 5% DEXTROSE INJECTION, USP
| Report ID | 229851 |
| Drug Identification Number | 00060348 |
| Brand name | 5% DEXTROSE INJECTION, USP |
| Common or Proper name | 5% Dextrose injection, USP |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE |
| Strength(s) | 5G |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 100 mL - JB0041P |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-06-07 |
| Actual start date | 2024-06-07 |
| Estimated end date | 2024-11-30 |
| Actual end date | 2024-11-30 |
| Shortage status | Resolved |
| Updated date | 2024-12-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.